SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹22,622 Cr | ₹18,194 Cr | ₹16,984 Cr | ₹19,906 Cr | ₹17,208 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹22,622 Cr |
| Mar2025 | ₹18,194 Cr |
| Mar2024 | ₹16,984 Cr |
| Mar2023 | ₹19,906 Cr |
| Mar2022 | ₹17,208 Cr |
How is Total Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹22,622 Cr | 24.34 | |
| Mar2025 | ₹18,194 Cr | 7.13 | |
| Mar2024 | ₹16,984 Cr | -14.68 | |
| Mar2023 | ₹19,906 Cr | 15.68 | |
| Mar2022 | ₹17,208 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,778.6 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| MANKIND PHARMA | ₹106,460.0 Cr | 1.2% | 6.6% | -5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
6.8% |
16.3% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses